Skip to main content

Table 1 Patient demographics

From: Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice

Characteristic

 

Age (years), mean ± SD

43 ± 10.9

Male, n (%)

15 (55.6)

AERD, n (%)

11 (40.7)

Asthma, n (%)

26 (96.3)

Number of previous sinus surgeries

 

 0

2

 1

8

 2

7

  ≥ 3

10

Baseline Lund-MacKay Score, mean ± SD

18.7 ± 4.9

Length of time on dupilumab (months), mean ± SD

12.1 ± 5.0

Time from last surgery to starting dupilumab (months), mean ± SD

31.1 ± 25.4

Total follow up time (months), mean ± SD

10.8 ± 5.1

  1. AERD aspirin exacerbated respiratory disease, SD standard deviation